CCAR2 and hepatocellular carcinoma: In hepatocellular carcinoma, elevated DBC1 expression is linked to higher TNM stages, poorer histological differentiation, and shorter survival times, suggesting its utility as an important marker for patient stratification and therapeutic planning.